Product Categories
Country: | China |
---|---|
Tel: | 13720134139 +86 -0-15871494362 |
Mobile: | 13720134139 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
C188-9 | C27H21NO5S | 432001-19-9 | Details |
Oxybutynin chloride | C22H32ClNO3 | 1508-65-2 | Details |
Reltecimod | C46H72N10O15S | 1447799-33-8 | Details |
DS-3201 | C26H34ClN3O4 | 1809336-39-7 | Details |
Atomoxetine HCL | C17H22ClNO | 82248-59-7 | Details |
5-Aza-2'-deoxycytidine | C8H12N4O4 | 2353-33-5 | Details |
ABT 263 | C47H55ClF3N5O6S3 | 923564-51-6 | Details |
Research Grade Bamlanivimab (DVV00303) | 2423943-37-5 | Details |
Pyrotinib dimaleate | C40H39ClN6O11 | 1397922-61-0 | Details |
GLP-1 | C186H275N51O59 | 87805-34-3 | Details |
Sabatolimab | 2252262-24-9 | Details |
orellanine | C10H8N2O6 | 37338-80-0 | Details |
Ravulizumab | 1803171-55-2 | Details |
MRTX-1257 | C33H39N7O2 | 2206736-04-9 | Details |
MRTX 9768 | C24H17FN6O | 2629314-68-5 | Details |
BMS-986177 | C28H23Cl2F2N9O2 | 1802425-99-5 | Details |
Remibrutinib | C27H27F2N5O3 | 1787294-07-8 | Details |
Melatonine | C13H16N2O2 | 73-31-4 | Details |
Ondansetron hydrochloride | C18H22ClN3O2 | 103639-04-9 | Details |
AG-270 | C18H24ClN3O3 | 13299-99-5 | Details |
Magrolimab | 2169232-81-7 | Details |
MRTX0902 | C22H24N6O | 2654743-22-1 | Details |
Adagrasib | C32H35ClFN7O2 | 2326521-71-3 | Details |
Research Grade Anti-Human CD152 | Details |
Research Grade Acazicolcept | 2270247-50-0 | Details |
Glumetinib | C21H17N9O2S | 1642581-63-2 | Details |
Research Grade Anti-Human CD19 | Details |
OUL 35 | C14H12N2O3 | 6336-34-1 | Details |
GR 89696 fumarate | C23H29Cl2N3O7 | 126766-32-3 | Details |
MYK-461 | C15H19N3O2 | 1642288-47-8 | Details |
NMDA-IN-1 | C20H23ClFN3O | 700878-19-9 | Details |
Chidamide | C22H19FN4O2 | 743420-02-2 | Details |
5-Carboxamidotryptamine maleate | C15H17N3O5 | 74885-72-6 | Details |
ITKinhibitor2 | C25H33N5O2 | 1309784-09-5 | Details |
TOFA | C19H32O4 | 54857-86-2 | Details |
WT-161 | C27H30N4O3 | 1206731-57-8 | Details |
PI 828 | C19H18N2O3 | 942289-87-4 | Details |
TP003 | C23H16F3N3O | 628690-75-5 | Details |
Acalabrutinib | C26H23N7O2 | 1420477-60-6 | Details |
IQ3 | C20H11N3O3 | 312538-03-7 | Details |
PD 180970 | C21H15Cl2FN4O | 287204-45-9 | Details |
Belzutifan | C17H12F3NO4S | 1672668-24-4 | Details |
Remimazolam Tosilate | C28H27BrN4O5S | 1425904-79-5 | Details |
Lonodelestat | C71H111N15O19 | 906547-89-5 | Details |
Capmatinib | C23H17FN6O | 1029712-80-8 | Details |
Trametinib DMSO solvate | C28H29FIN5O5S | 1187431-43-1 | Details |
Dabrafenib Mesylate | C24H24F3N5O5S3 | 1195768-06-9 | Details |
IEM1754dihydrobroMide | C16H32Br2N2 | 162831-31-4 | Details |
KIRA6 | C28H25F3N6O | 1589527-65-0 | Details |
PA-8 | C17H18N4O4 | 878437-15-1 | Details |
CNV 1014802 hydrochloride | C18H20ClFN2O2 | 934240-31-0 | Details |
Silybin A | C25H22O10 | 22888-70-6 | Details |
Rocatinlimab | 2431972-52-8 | Details |
6-OH-BTA-1 | C14H12N2OS | 566169-93-5 | Details |
Mirikizumab | 1884201-71-1 | Details |
Ponatinib Mono-hydrochloride | C29H28ClF3N6O | 1114544-31-8 | Details |
Formoterol fumarate dihydrate | C23H28N2O8 | 183814-30-4 | Details |
TPX-0005 | C18H18FN5O2 | 1802220-02-5 | Details |
Gilteritinib | C29H44N8O3 | 1254053-43-4 | Details |
Ponatinib | C29H27F3N6O | 943319-70-8 | Details |
Research Grade Sotatercept (DHC33102) | 1001080-50-7 | Details |
Glasdegib | C21H22N6O | 1095173-27-5 | Details |
Capmatinib 2HCl | C23H18ClFN6O | 1197376-85-4 | Details |
Sotorasib | C30H30F2N6O3 | 2296729-00-3 | Details |
Lorlatinib | C21H19FN6O2 | 1454846-35-5 | Details |
GSK 343 | C31H39N7O2 | 1346704-33-3 | Details |
Fruquintinib|HMPL-013 | C21H19N3O5 | 1194506-26-7 | Details |
(R)-2-((tert-butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid | C8H12F3NO4 | 1354225-89-0 | Details |
Apremilast Impurity 1 | C23H26N2O8S | 2487573-01-1 | Details |
(S)-2-((tert-Butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid | C8H12F3NO4 | 1932644-89-7 | Details |
(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3,3,3-trifluoropropanoicacid | C18H14F3NO4 | 1704706-86-4 | Details |
Research Grade Spesolimab | 2097104-58-8 | Details |
Futibatinib | C22H22N6O3 | 1448169-71-8 | Details |
intermediate | C19H23NO2 | 722520-42-5 | Details |
Brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
2-Fluoro-4-nitrobenzoic acid | C7H4FNO4 | 403-24-7 | Details |
camlipixant | C23H24F2N4O4 | 1621164-74-6 | Details |
FAP-2286 | C67H99N13O18S3 | 2581741-18-4 | Details |
Tislelizumab | 1858168-59-8 | Details |
Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
Leniolisibphosphate | C21H28F3N6O6P | 1354691-97-6 | Details |
Pemigatinib | C24H27F2N5O4 | 1513857-77-6 | Details |
Cabergoline EP Impurity D | C23H32N4O | 85329-86-8 | Details |
Cabergoline EP Impurity E | C19H22N2O2 | 86891-16-9 | Details |
Cabergoline EP Impurity G | C22H30N4O | 478815-26-8 | Details |
Cabergoline EP Impurity F | C18H20N2O2 | 86891-15-8 | Details |
Cabergoline EP Impurity J | C23H33N5O2 | 153415-36-2 | Details |
Cabergoline EP Impurity B | C26H37N5O2 | 166533-36-4 | Details |
Cabergoline EP Impurity C | C29H42N6O3 | 126554-50-5 | Details |
6-ethyl-1,2,3,4-tetrahydroanthraquinone | C16H16O2 | 15547-17-8 | Details |
Cefepime | C19H24N6O5S2 | 88040-23-7 | Details |
Ethyl3-oxo-3-(4-nitrophenyl)propanoate | C11H11NO5 | 838-57-3 | Details |
6-Amino-2-(4-dimethylaminophenyl)benzothiazole | C15H15N3S | 909191-20-4 | Details |
Maleimido-mono-amide-DOTA | C22H34N6O9 | 1006711-90-5 | Details |
Cabergoline EP Impurity A | C18H20N2O2 | "81409-74-7 | Details |
6-OH-BTA-0 | C13H10N2OS | 178804-18-7 | Details |
2-Ethyl Anthraquinone | C16H12O2 | 84-51-5 | Details |
Xanthene | C13H10O | 92-83-1 | Details |
Ripretinib | C24H21BrFN5O2 | 1442472-39-0 | Details |
EGFR-IN-7 | C32H41BrN9O2P | 2267329-76-8 | Details |
Product Total: Product Page: | ||||
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 |